Logo
x

Search category

Subscribe Now

All Posts by Date

Genentech and Novartis's Xolair (omalizumab) Receives the FDA's Approval for Adults with Nasal Polyps

Genentech and Novartis's Xolair (omalizumab) Receives the FDA's Approval for Adults with Nasal Polyps

BioNTech and Pfizer Report CMA Submission of BNT162b2 to EMA for COVID-19

BioNTech and Pfizer Report CMA Submission of BNT162b2 to EMA for COVID-19

Boston Scientific to Divest BTG's Specialty Pharma Business for ~$800M

Boston Scientific to Divest BTG's Specialty Pharma Business for ~$800M

Regeneron Collaborates with Penn to Explore Intranasal Delivery of COVID-19 Ab Cocktail via Gene Therapy Platform

Regeneron Collaborates with Penn to Explore Intranasal Delivery of COVID-19 Ab Cocktail via Gene Therapy Platform

AstraZeneca to Divest European Rights of Crestor (rosuvastatin) to Grünenthal for ~$350M

AstraZeneca to Divest European Rights of Crestor (rosuvastatin) to Grünenthal for ~$350M

Roche's Gavreto (pralsetinib) Receives the US FDA's Approval for Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancers

Roche's Gavreto (pralsetinib) Receives the US FDA's Approval for Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid...

Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2022 PharmaShots - All Rights Reserved.